Status:
UNKNOWN
COVID-19 : Transcutaneous pO2 and pCO2 as Predictive Factors for Acute Respiratory Destress Syndrome in Patients Affected With SARS-Cov-2
Lead Sponsor:
Erasme University Hospital
Conditions:
COVID
Acute Respiratory Distress Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The first case of a person infected with SARS-Cov-2 virus can be tracked back on November the 17th, 2019, in China. On March 11, 2020, the World Health Organization (WHO) declared COVID-19 outbreak a ...
Eligibility Criteria
Inclusion
- SARS-CoV2 infection (PCR positive and/or TDM Imaging)
Exclusion
- None
Key Trial Info
Start Date :
October 4 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 4 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04524156
Start Date
October 4 2020
End Date
May 4 2023
Last Update
August 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Erasme Hospital
Brussels, Belgium, 1070